Global Dry Powder Inhaler Device Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
The global total sales of dry powder inhaler device is nearly 49674 K units in 2015.
Market Analysis and Insights: Global Dry Powder Inhaler Device Market
The global Dry Powder Inhaler Device market size is projected to reach US$ 999.1 million by 2026, from US$ 749.8 million in 2020, at a CAGR of 4.9% during 2021-2026.
Global Dry Powder Inhaler Device Scope and Segment
The global Dry Powder Inhaler Device market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dry Powder Inhaler Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
Segment by Type, the Dry Powder Inhaler Device market is segmented into
Single Dose
Multi-dose
Segment by Application, the Dry Powder Inhaler Device market is segmented into
Asthma
COPD
Other
Dry Powder Inhaler Device market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dry Powder Inhaler Device business, the date to enter into the Dry Powder Inhaler Device market, Dry Powder Inhaler Device product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Dry Powder Inhaler Device markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Dry Powder Inhaler Device market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
The global total sales of dry powder inhaler device is nearly 49674 K units in 2015.
Market Analysis and Insights: Global Dry Powder Inhaler Device Market
The global Dry Powder Inhaler Device market size is projected to reach US$ 999.1 million by 2026, from US$ 749.8 million in 2020, at a CAGR of 4.9% during 2021-2026.
Global Dry Powder Inhaler Device Scope and Segment
The global Dry Powder Inhaler Device market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dry Powder Inhaler Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
Segment by Type, the Dry Powder Inhaler Device market is segmented into
Single Dose
Multi-dose
Segment by Application, the Dry Powder Inhaler Device market is segmented into
Asthma
COPD
Other
Dry Powder Inhaler Device market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dry Powder Inhaler Device business, the date to enter into the Dry Powder Inhaler Device market, Dry Powder Inhaler Device product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Dry Powder Inhaler Device markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. Key regions covered in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Dry Powder Inhaler Device market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
